Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-24T06:34:50.735Z Has data issue: false hasContentIssue false
  • English
  • Français

Practical clinical trials for schizophrenia

Published online by Cambridge University Press:  11 October 2011

Scott Stroup
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
Epidemiology and Psychiatric Sciences , Volume 14 , Issue 3 , September 2005 , pp. 132 - 136
Copyright
Copyright © Cambridge University Press 2005

References

REFERENCES

Als-Nielsen, B., Chen, W., Gluud, C. & Kjaergard, Lise L. (2003). Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? Journal of American Medical Association 290, 921–928.Google Scholar
Essock, S.M., Drake, R.E., Frank, R.G. & McGuire, T.G. (2003). Randomized controlled trials in evidence-based mental health care: getting the right answer to the right question Schizophrenia Bulletin 29, 115–123.CrossRefGoogle Scholar
Ioannidis, J.P., Evans, S.J., Gotzsche, P.C., O'Neill, R., Altman, D.G., Schulz, K. & Moher, D. for the CONSORT Group (2004). Better reporting of harms in randomized trials: an extension of the CON-SORT statement Annals of Internetional Medicine 141, 781–788.CrossRefGoogle ScholarPubMed
Institute of Medicine (1985). Assessing Medical Technologies. National Academy Press: Washington, DC.Google Scholar
Moher, D., Schulz, K.F. & Altman, D. (2001). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Journal of American Medical Association 285, 1987–1991.CrossRefGoogle Scholar
Rosenheck, R.A. (2005). Open forum: effectiveness versus efficacy of second-generation antipsychotics: haloperidol without anticholinergics as a comparator Psychiatric Services 56, 85–92.CrossRefGoogle ScholarPubMed
Stroup, T.S., McEvoy, J.P., Swartz, M.S., Byerly, M.J., Glick, I.D., Canive, J.M., McGee, M.F., Simpson, G.M., Stevens, M.C. & Lieberman, J.A. (2003). The NIMH-CATIE Project: Schizophrenia Trial Design and Protocol Development. Schizophrenia Bulletin 29(1), 15–31.CrossRefGoogle Scholar
Tunis, S.R., Stryer, D.B. & Clancy, CM. (2003). Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Journal of American Medical Association 290, 1624–1632.CrossRefGoogle ScholarPubMed